A New Era with the Development of Cytokine-Based Therapy for Pruritus

Volume: 142, Issue: 1, Pages: 47 - 52
Published: Jan 1, 2022
Abstract
Pruritus is a common dermatological condition and negatively impacts QOL. Persistent pruritus and excessive scratching behavior can lead to the itch-scratch cycle that exacerbates inflammatory skin diseases. Conventional antipruritic drugs, such as antihistamines, corticosteroids, or anticonvulsants, are sometimes insufficient. Recently, however, molecularly targeted drugs, such as IL-31 or IL-4 receptor-targeting antibodies, have become...
Paper Details
Title
A New Era with the Development of Cytokine-Based Therapy for Pruritus
Published Date
Jan 1, 2022
Volume
142
Issue
1
Pages
47 - 52
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.